2.1 Study population
adenomatous polyps, infection, intestinal diseases, colorectal polyps, diabetes
COLONIC CANCER, ADENOMATOUS POLYPS, DIABETES, INFECTION, INTESTINAL DISEASES, INFLAMMATORY POLYPS, PROLIFERATIVE, COLORECTAL POLYPS
Ethical approval was granted by the Ethics Committee of the Affifiliated Hospital of Jiangnan University, Wuxi, China (LS2022022), and this preliminary trial was registered at the Chinese Clinical Trial Registry (ChiCTR2200063806). All participants were 18–80 years old and were voluntarily enrolled prior to presenting for colonoscopy. Twenty-four patients with colorectal polyps were classified as the polyps group, while 16 healthy individuals were classified as the control group. The inclusion criteria including patients: 1. were diagnosed with proliferative polyps, inflammatory polyps and adenomatous polyps by colonoscopy and pathological results; Those patients: 1. with history of colonic cancer, colonic polyps or diabetes; 2. with use of antibiotics or probiotics in the past three months; 3. with symptoms of infection within 1 week; 4. with other intestinal diseases were excluded.